InvestorsHub Logo
Followers 21
Posts 1331
Boards Moderated 0
Alias Born 06/28/2020

Re: None

Wednesday, 10/11/2023 9:48:24 AM

Wednesday, October 11, 2023 9:48:24 AM

Post# of 36602
The News.. Under an agreement with the University of Waterloo, formulation development is ongoing and aims to be completed by the end of December 2023. So that's what I meant CW. etc. by news not until Dec....that I'm waiting on lol anyway.
https://www.globenewswire.com/news-release/2023/10/11/2758381/0/en/Revive-Therapeutics-Provides-Update-of-Novel-Bucillamine-Formulation-Development.html